141 related articles for article (PubMed ID: 37880023)
1. Incidence of fibrosing colonopathy with pancreatic enzyme replacement therapy in patients with cystic fibrosis.
Chiuve SE; Fife D; Leitz G; Peterson C; Campbell NM; Rennig A; Rodrigues L; Decktor D; Dowd C; Marshall BC; Borowitz D
J Cyst Fibros; 2023 Nov; 22(6):1017-1023. PubMed ID: 37880023
[TBL] [Abstract][Full Text] [Related]
2. Correlates of Pancreatic Enzyme Replacement Therapy Intake in Adults with Cystic Fibrosis: Results of a Cross-Sectional Study.
Olsen MF; Kjøller-Svarre MS; Møller G; Katzenstein TL; Nielsen BU; Pressler T; Lewis JI; Mathiesen IH; Mølgaard C; Faurholt-Jepsen D
Nutrients; 2022 Mar; 14(7):. PubMed ID: 35405943
[TBL] [Abstract][Full Text] [Related]
3. High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis.
FitzSimmons SC; Burkhart GA; Borowitz D; Grand RJ; Hammerstrom T; Durie PR; Lloyd-Still JD; Lowenfels AB
N Engl J Med; 1997 May; 336(18):1283-9. PubMed ID: 9113931
[TBL] [Abstract][Full Text] [Related]
4. Pancreatic enzyme supplementation in cystic fibrosis patients before and after fibrosing colonopathy.
Stevens JC; Maguiness KM; Hollingsworth J; Heilman DK; Chong SK
J Pediatr Gastroenterol Nutr; 1998 Jan; 26(1):80-4. PubMed ID: 9443125
[TBL] [Abstract][Full Text] [Related]
5. Preliminary report of the (13)C-mixed triglyceride breath test to assess timing of pancreatic enzyme replacement therapy in children with cystic fibrosis.
van der Haak N; Boase J; Davidson G; Butler R; Miller M; Kaambwa B; Kritas S
J Cyst Fibros; 2016 Sep; 15(5):669-74. PubMed ID: 27102891
[TBL] [Abstract][Full Text] [Related]
6. Clinical evaluation of an evidence-based method based on food characteristics to adjust pancreatic enzyme supplements dose in cystic fibrosis.
Calvo-Lerma J; Boon M; Colombo C; de Koning B; Asseiceira I; Garriga M; Roca M; Claes I; Bulfamante A; Walet S; Pereira L; Ruperto M; Masip E; Asensio-Grau A; Giana A; Affourtit P; Heredia A; Vicente S; Andrés A; de Boeck K; Hulst J; Ribes-Koninckx C
J Cyst Fibros; 2021 Sep; 20(5):e33-e39. PubMed ID: 33279468
[TBL] [Abstract][Full Text] [Related]
7. Timing of pancreatic enzyme replacement therapy (PERT) in cystic fibrosis.
Ng C; Major G; Smyth AR
Cochrane Database Syst Rev; 2021 Aug; 8(8):CD013488. PubMed ID: 34339047
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic enzyme replacement therapy in cystic fibrosis: Australian guidelines. Pediatric Gastroenterological Society and the Dietitians Association of Australia.
Anthony H; Collins CE; Davidson G; Mews C; Robinson P; Shepherd R; Stapleton D
J Paediatr Child Health; 1999 Apr; 35(2):125-9. PubMed ID: 10365346
[TBL] [Abstract][Full Text] [Related]
9. Porcine-derived pancreatic enzyme replacement therapy may be linked to chronic hepatitis E virus infection in cystic fibrosis lung transplant recipients.
Thornton CS; Waddell BJ; Congly SE; Svishchuk J; Somayaji R; Fatovich L; Isaac D; Doucette K; Fonseca K; Drews SJ; Borlang J; Osiowy C; Parkins MD
Gut; 2024 Apr; ():. PubMed ID: 38621922
[TBL] [Abstract][Full Text] [Related]
10. Coefficient of Fat Absorption to Measure the Efficacy of Pancreatic Enzyme Replacement Therapy in People With Cystic Fibrosis: Gold Standard or Coal Standard?
Borowitz D; Aronoff N; Cummings LC; Maqbool A; Mulberg AE
Pancreas; 2022 Apr; 51(4):310-318. PubMed ID: 35695742
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic enzyme replacement therapy for people with cystic fibrosis.
Somaraju URR; Solis-Moya A
Cochrane Database Syst Rev; 2020 Aug; 8(8):CD008227. PubMed ID: 32761612
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic Enzyme Replacement Therapy Use in Infants With Cystic Fibrosis Diagnosed by Newborn Screening.
Gelfond D; Heltshe SL; Skalland M; Heubi JE; Kloster M; Leung DH; Ramsey BW; Borowitz D;
J Pediatr Gastroenterol Nutr; 2018 Apr; 66(4):657-663. PubMed ID: 29176494
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic enzyme replacement therapy in cystic fibrosis: dose, variability and coefficient of fat absorption.
Calvo-Lerma J; Martínez-Barona S; Masip E; Fornés V; Ribes-Koninckx C
Rev Esp Enferm Dig; 2017 Oct; 109(10):684-689. PubMed ID: 28747058
[TBL] [Abstract][Full Text] [Related]
14. Nutritional status, nutrient intake and use of enzyme supplements in paediatric patients with Cystic Fibrosis; a European multicentre study with reference to current guidelines.
Calvo-Lerma J; Hulst JM; Asseiceira I; Claes I; Garriga M; Colombo C; Fornés V; Woodcock S; Martins T; Boon M; Ruperto M; Walet S; Speziali C; Witters P; Masip E; Barreto C; de Boeck K; Ribes-Koninckx C;
J Cyst Fibros; 2017 Jul; 16(4):510-518. PubMed ID: 28320633
[TBL] [Abstract][Full Text] [Related]
15. Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants (most commonly F508del).
Southern KW; Murphy J; Sinha IP; Nevitt SJ
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD010966. PubMed ID: 33331662
[TBL] [Abstract][Full Text] [Related]
16. Fibrosing colonopathy in children with cystic fibrosis.
Reichard KW; Vinocur CD; Franco M; Crisci KL; Flick JA; Billmire DF; Schidlow DV; Weintraub WH
J Pediatr Surg; 1997 Feb; 32(2):237-41; discussion 241-2. PubMed ID: 9044129
[TBL] [Abstract][Full Text] [Related]
17. Maximal daily dose of pancreatic enzyme replacement therapy in infants with cystic fibrosis: a reconsideration.
Borowitz D; Gelfond D; Maguiness K; Heubi JE; Ramsey B
J Cyst Fibros; 2013 Dec; 12(6):784-5. PubMed ID: 23809508
[TBL] [Abstract][Full Text] [Related]
18. CREON (Pancrelipase Delayed-Release Capsules) for the treatment of exocrine pancreatic insufficiency.
Kuhn RJ; Gelrud A; Munck A; Caras S
Adv Ther; 2010 Dec; 27(12):895-916. PubMed ID: 21086085
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic Enzyme Replacement Therapy in Cystic Fibrosis.
Freswick PN; Reid EK; Mascarenhas MR
Nutrients; 2022 Mar; 14(7):. PubMed ID: 35405954
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic Enzyme Replacement Therapy and Coefficient of Fat Absorption in Children and Adolescents With Cystic Fibrosis.
Woestenenk JW; van der Ent CK; Houwen RH
J Pediatr Gastroenterol Nutr; 2015 Sep; 61(3):355-60. PubMed ID: 25782658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
